Free Trial

MetLife, Inc. (NYSE:MET) Shares Sold by GSA Capital Partners LLP

MetLife logo with Finance background

GSA Capital Partners LLP lowered its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 59.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,217 shares of the financial services provider's stock after selling 10,425 shares during the quarter. GSA Capital Partners LLP's holdings in MetLife were worth $595,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of MET. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after buying an additional 277 shares during the period. Fortitude Family Office LLC lifted its position in shares of MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after acquiring an additional 266 shares during the period. Venturi Wealth Management LLC grew its holdings in shares of MetLife by 37.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 533 shares of the financial services provider's stock worth $44,000 after acquiring an additional 144 shares during the period. Finally, Bank & Trust Co purchased a new position in MetLife in the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 89.81% of the company's stock.

MetLife Trading Down 0.9 %

Shares of NYSE:MET traded down $0.74 during trading on Tuesday, reaching $82.63. 2,349,563 shares of the stock were exchanged, compared to its average volume of 3,319,819. The firm's 50-day moving average price is $81.76 and its 200 day moving average price is $75.71. The firm has a market cap of $57.21 billion, a price-to-earnings ratio of 16.81, a price-to-earnings-growth ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 12-month low of $61.85 and a 12-month high of $86.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.64%. MetLife's dividend payout ratio is currently 43.95%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Wells Fargo & Company increased their price target on shares of MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. Morgan Stanley reduced their target price on MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research note on Monday, August 19th. Bank of America dropped their price target on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research report on Thursday, August 1st. Finally, Jefferies Financial Group increased their price objective on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research note on Friday, September 27th. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, MetLife has an average rating of "Buy" and an average price target of $88.46.

Read Our Latest Stock Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines